The Price of Drugs: Investing amid pharma's politics

Drug pricing always comes with political noise, particularly when US elections are concerned. Over the last year, the share prices of pharmaceutical and biotech companies on both sides of the Atlantic have continually swung on the tweets and proclamations of politicians.In this special podcast, IC companies writer Megan Boxall speaks with industry insiders and tries to cut through the controversy and policy rumblings, to assess whether there are still good reasons to view pharma and biotech companies as worthwhile investments. Produced by Alex Newman and Dominic Toms, with music from Blue Dot Sessions. News clips courtesy of Fox.

Hosted on Acast. See acast.com/privacy for more information.

More from Investors' Chronicle

  1. 34:36BHP’s bid for Anglo & investors’ biggest mistakes: The Companies and Markets ShowApr 26, 2024
  2. 35:31Fundsmith’s fate, industrial metals, & Asos: The Companies and Markets ShowApr 19, 2024
  3. 36:51British bargains & heritage brands: The Companies and Markets ShowApr 12, 2024
  4. 31:19‘It’s exciting in the investment trust sphere': Joe Bauernfreund of AVIApr 09, 2024
  5. 31:47Tesla woes, travel’s rebound & investing during rate cuts: The Companies and Markets Show Apr 05, 2024
  6. 31:37Britain’s top-rated funds & Fevertree: The Companies and Markets ShowMar 28, 2024
  7. 41:24‘Cultural attitudes around investing need to change’: Lee and the ICMar 26, 2024
  8. 36:01Vodafone’s fortunes & UK’s tech stocks: The Companies and Markets ShowMar 22, 2024
  9. 47:59'We should redefine what a recession is': Abby Glennie of Abrdn UK Smaller Companies fundMar 19, 2024
  10. 40:31The Isa Special 2024: The Companies and Markets ShowMar 15, 2024